This article is an open access article distributed under the terms and conditions of the Creative... more This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY
This is a PDF file of an article that has undergone enhancements after acceptance, such as the ad... more This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
<p>Results of logistic regression analysis to evaluate characteristics of participants in t... more <p>Results of logistic regression analysis to evaluate characteristics of participants in the test, treat, and prevent HIV program associated with prevalent HIV infection, Thailand, 2015–2016.</p
<p>Knowledge and attitudes of test, treat, and prevent HIV program participants about HIV i... more <p>Knowledge and attitudes of test, treat, and prevent HIV program participants about HIV infection, antiretrovirals, and pre-exposure prophylaxis, Thailand, 2015–2016.</p
<p>Results of logistic regression analysis evaluating characteristics of HIV-uninfected par... more <p>Results of logistic regression analysis evaluating characteristics of HIV-uninfected participants in the test, treat, and prevent HIV program at Lerdsin and Thammasat University Hospitals who chose to start HIV pre-exposure prophylaxis (PrEP), Thailand, 2015–2016.</p
<p>Results of logistic regression analysis evaluating characteristics of participants in th... more <p>Results of logistic regression analysis evaluating characteristics of participants in the test, treat, and prevent HIV program with prevalent HIV infection who chose to start antiretroviral therapy (ART), Thailand, 2015–2016.</p
Motywacja: W 2011 roku Rada Ministrów wprowadziła Program wspierania inwestycji o szczególnym zna... more Motywacja: W 2011 roku Rada Ministrów wprowadziła Program wspierania inwestycji o szczególnym znaczeniu dla gospodarki polskiej na lata 2011–2020. Głównym jego celem jest zachęcanie inwestorów zagranicznych do lokowania w Polsce inwestycji zaawansowanych technologicznie. Jednocześnie zawarto w nim kryteria lokalizacyjne mające zachęcać do inwestycji w słabiej rozwiniętych regionach. Motywem wyboru tematu jest zbadanie, w jaki sposób oba aspekty programu wpływają na decyzje lokalizacyjne inwestorów zagranicznych. Cel: Celem artykułu jest próba oceny wpływu czynników lokalizacyjnych, powiązanych ze specyfiką wspieranych przez program typów inwestycji oraz bezpośrednich zachęt w nim zawartych na decyzje inwestorów zagranicznych. Materiały i metody: Pozyskano informacje dotyczące projektów z publicznie dostępnych źródeł, jak również instytucji zaangażowanej w obsługę inwestorów zagranicznych. Dane powiązano ze sobą oraz poddano analizie z wykorzystaniem pakietu ekonometrycznego. Wyniki:...
New evidence has emerged regarding when to commence antiretroviral therapy (ART), optimal treatme... more New evidence has emerged regarding when to commence antiretroviral therapy (ART), optimal treatment regimens, management of HIV co-infection with opportunistic infections, and management of ART failure. The 2014 guidelines were developed by the collaborations of the Department of Disease Control, Ministry of Public Health (MOPH) and the Thai AIDS Society (TAS). One of the major changes in the guidelines included recommending to initiating ART irrespective of CD4 cell count. However, it is with an emphasis that commencing HAART at CD4 cell count above 500 cell/mm 3 is for public health, in term of preventing HIV transmission and personal benefit. In tuberculosis co-infected patients with CD4 cell counts ≤50 cells/mm 3 or with CD4 cell counts >50 cells/mm 3 who have severe clinical disease, ART should be initiated within 2 weeks of starting tuberculosis treatment. The preferred initial ART regimen in treatment naïve patients is efavirenz combined with tenofovir and emtricitabine or lamivudine. Plasma HIV viral load assessment should be done twice a year until achieving undetectable results; and will then be monitored once a year. CD4 cell count should be monitored every 6 months until CD4 cell count ≥350 cells/mm 3 and with plasma HIV viral load <50 copies/mL; then it should be monitored once a year afterward. HIV drug resistance genotypic test is indicated when plasma HIV viral load >1,000 copies/mL while on ART. Ritonavir-boosted lopinavir or atazanavir in combination with optimized two nucleoside-analogue reverse transcriptase inhibitors is recommended after initial ART regimen failure. Long-term ART-related safety monitoring has also been included in the guidelines.
STIQUAL model is a sexually transmitted infection (STI) services quality improvement (QI) model i... more STIQUAL model is a sexually transmitted infection (STI) services quality improvement (QI) model initiated in 2009 under the “STI quality performance measurement” project. It was an effort to strengthen the quality of STI screening care and treatment, data and information system and enhance the access to STI and HIV care of key populations. STIQUAL program, the tool for performance measurement (PM) was developed in 2009-2010 and piloted in some selected provinces in 2011-2112. The objec-tive of this study was to evaluate the project for 4 categories: (1) the capacity of the tool in measuring STI performances; (2) the PM resulted in STI service QI; (3) increasing knowledge, skill, satisfaction of health personnel, and (4) factors supporting the QI. It was conducted as a descriptive study during August- December 2015. Data on key indicators were gathered from STIQUAL program during 2009-2012 and STI/VCT mini record program during 2013-2014, which were collected 3 times at least 1 year ...
Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can p... more Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can prevent HIV transmission. We implemented a Test, Treat, and Prevent HIV Program among men who have sex with men (MSM) and transgender women at five hospitals in four provinces of Thailand to increase HIV testing, help those who test positive start antiretroviral therapy, and increase access to pre-exposure prophylaxis (PrEP). We implemented rapid HIV testing and trained staff on immediate antiretroviral initiation at the five hospitals and offered PrEP at two hospitals. We recruited MSM and transgender women who walked-in to clinics and used a peer-driven intervention to expand recruitment. We used logistic regression to determine factors associated with prevalent HIV infection and the decision to start antiretroviral therapy and PrEP. During 2015 and 2016, 1880 people enrolled. Participants recruited by peers were younger (p<0.0001), less likely to be HIV-infected (p<0.0001), and t...
This article is an open access article distributed under the terms and conditions of the Creative... more This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY
This is a PDF file of an article that has undergone enhancements after acceptance, such as the ad... more This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
<p>Results of logistic regression analysis to evaluate characteristics of participants in t... more <p>Results of logistic regression analysis to evaluate characteristics of participants in the test, treat, and prevent HIV program associated with prevalent HIV infection, Thailand, 2015–2016.</p
<p>Knowledge and attitudes of test, treat, and prevent HIV program participants about HIV i... more <p>Knowledge and attitudes of test, treat, and prevent HIV program participants about HIV infection, antiretrovirals, and pre-exposure prophylaxis, Thailand, 2015–2016.</p
<p>Results of logistic regression analysis evaluating characteristics of HIV-uninfected par... more <p>Results of logistic regression analysis evaluating characteristics of HIV-uninfected participants in the test, treat, and prevent HIV program at Lerdsin and Thammasat University Hospitals who chose to start HIV pre-exposure prophylaxis (PrEP), Thailand, 2015–2016.</p
<p>Results of logistic regression analysis evaluating characteristics of participants in th... more <p>Results of logistic regression analysis evaluating characteristics of participants in the test, treat, and prevent HIV program with prevalent HIV infection who chose to start antiretroviral therapy (ART), Thailand, 2015–2016.</p
Motywacja: W 2011 roku Rada Ministrów wprowadziła Program wspierania inwestycji o szczególnym zna... more Motywacja: W 2011 roku Rada Ministrów wprowadziła Program wspierania inwestycji o szczególnym znaczeniu dla gospodarki polskiej na lata 2011–2020. Głównym jego celem jest zachęcanie inwestorów zagranicznych do lokowania w Polsce inwestycji zaawansowanych technologicznie. Jednocześnie zawarto w nim kryteria lokalizacyjne mające zachęcać do inwestycji w słabiej rozwiniętych regionach. Motywem wyboru tematu jest zbadanie, w jaki sposób oba aspekty programu wpływają na decyzje lokalizacyjne inwestorów zagranicznych. Cel: Celem artykułu jest próba oceny wpływu czynników lokalizacyjnych, powiązanych ze specyfiką wspieranych przez program typów inwestycji oraz bezpośrednich zachęt w nim zawartych na decyzje inwestorów zagranicznych. Materiały i metody: Pozyskano informacje dotyczące projektów z publicznie dostępnych źródeł, jak również instytucji zaangażowanej w obsługę inwestorów zagranicznych. Dane powiązano ze sobą oraz poddano analizie z wykorzystaniem pakietu ekonometrycznego. Wyniki:...
New evidence has emerged regarding when to commence antiretroviral therapy (ART), optimal treatme... more New evidence has emerged regarding when to commence antiretroviral therapy (ART), optimal treatment regimens, management of HIV co-infection with opportunistic infections, and management of ART failure. The 2014 guidelines were developed by the collaborations of the Department of Disease Control, Ministry of Public Health (MOPH) and the Thai AIDS Society (TAS). One of the major changes in the guidelines included recommending to initiating ART irrespective of CD4 cell count. However, it is with an emphasis that commencing HAART at CD4 cell count above 500 cell/mm 3 is for public health, in term of preventing HIV transmission and personal benefit. In tuberculosis co-infected patients with CD4 cell counts ≤50 cells/mm 3 or with CD4 cell counts >50 cells/mm 3 who have severe clinical disease, ART should be initiated within 2 weeks of starting tuberculosis treatment. The preferred initial ART regimen in treatment naïve patients is efavirenz combined with tenofovir and emtricitabine or lamivudine. Plasma HIV viral load assessment should be done twice a year until achieving undetectable results; and will then be monitored once a year. CD4 cell count should be monitored every 6 months until CD4 cell count ≥350 cells/mm 3 and with plasma HIV viral load <50 copies/mL; then it should be monitored once a year afterward. HIV drug resistance genotypic test is indicated when plasma HIV viral load >1,000 copies/mL while on ART. Ritonavir-boosted lopinavir or atazanavir in combination with optimized two nucleoside-analogue reverse transcriptase inhibitors is recommended after initial ART regimen failure. Long-term ART-related safety monitoring has also been included in the guidelines.
STIQUAL model is a sexually transmitted infection (STI) services quality improvement (QI) model i... more STIQUAL model is a sexually transmitted infection (STI) services quality improvement (QI) model initiated in 2009 under the “STI quality performance measurement” project. It was an effort to strengthen the quality of STI screening care and treatment, data and information system and enhance the access to STI and HIV care of key populations. STIQUAL program, the tool for performance measurement (PM) was developed in 2009-2010 and piloted in some selected provinces in 2011-2112. The objec-tive of this study was to evaluate the project for 4 categories: (1) the capacity of the tool in measuring STI performances; (2) the PM resulted in STI service QI; (3) increasing knowledge, skill, satisfaction of health personnel, and (4) factors supporting the QI. It was conducted as a descriptive study during August- December 2015. Data on key indicators were gathered from STIQUAL program during 2009-2012 and STI/VCT mini record program during 2013-2014, which were collected 3 times at least 1 year ...
Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can p... more Antiretroviral therapy reduces the risk of serious illness among people living with HIV and can prevent HIV transmission. We implemented a Test, Treat, and Prevent HIV Program among men who have sex with men (MSM) and transgender women at five hospitals in four provinces of Thailand to increase HIV testing, help those who test positive start antiretroviral therapy, and increase access to pre-exposure prophylaxis (PrEP). We implemented rapid HIV testing and trained staff on immediate antiretroviral initiation at the five hospitals and offered PrEP at two hospitals. We recruited MSM and transgender women who walked-in to clinics and used a peer-driven intervention to expand recruitment. We used logistic regression to determine factors associated with prevalent HIV infection and the decision to start antiretroviral therapy and PrEP. During 2015 and 2016, 1880 people enrolled. Participants recruited by peers were younger (p<0.0001), less likely to be HIV-infected (p<0.0001), and t...
Uploads
Papers by ake Sukkul